Variable | Magnesium group | Placebo group | Â | Â | ||
---|---|---|---|---|---|---|
Value | P1 | Value | P1 | P2 | P3 | |
SF-36 MCS score | ||||||
Baseline | 63.50 ± 16.90 | 0.003 | 66.19 ± 19.26 | 0.109 | 0.38 |  |
End of the study | 78.59 ± 15.73 | 68.22 ± 17.43 | 0.03 |  | ||
Changes | 15.09 ± 11.90 |  | 2.03 ± 10.52 |  | < 0.001 | 0.03 |
SF-36 PCS score | ||||||
Baseline | 78.36 ± 17.45 | 0.001 | 80.16 ± 20.15 | 0.39 | 0.45 |  |
End of the study | 95.14 ± 19.22 | 83.44 ± 18.67 | 0.03 |  | ||
Changes | 16.78 ± 14.32 |  | 3.28 ± 12.35 |  | 0.01 | 0.02 |
BDI total score | ||||||
Baseline | 21.98 ± 1.5 | 0.001 | 20.75 ± 1.44 | 0.53 | 0.87 |  |
End of the study | 16.78 ± 1.83 | 19.12 ± 1.65 | 0.12 |  | ||
Changes | -5.24 ± 0.76 |  | -1.63 ± 0.68 |  | 0.03 | 0.03 |
State anxiety | Â | Â | Â | Â | Â | Â |
Baseline | 42.15 ± 26.33 | 0.03 | 17.43 ± 2.25 | 0.04 | 0.31 |  |
End of the study | 36.19 ± 27.19 | 15.68 ± 3.72 | 0.08 |  | ||
Changes | -5.96 ± 15.53 |  | -2.92 ± 13.63 |  | 0.104 | 0.126 |